Skip to content
Call Us Today! 1.555.555.555|info@yourdomain.com
San Francisco Product Liability & Mesothelioma Attorneys Logo

Empowering People
Hurt by Big Businesses
Local (415) 857-7400
Toll Free (800) 824-8234

  • Home
  • Practice Areas
    • Defective Medical Devices
    • Defective Pharmaceuticals
    • Asbestos
    • Mesothelioma
    • Combat Ear Plugs
  • About Us
    • Our Attorneys
      • Jeffrey A. Kaiser
      • Lawrence J. Gornick
    • Our History
    • Community Involvement
  • Selecting a Law Firm
  • News
    • News Blog
      • Blog Posts in 2018
      • Blog Posts in 2017
      • Blog Posts in 2016
      • Blog Posts in 2015
      • Blog Posts in 2014
      • Blog Posts in 2013
      • Blog Posts in 2012
      • Blog Posts in 2010
    • Legal Articles
    • Press Releases
  • Contact Us

Blog Posts in 2012

  • Our History
  • Client Testimonials
  • Case Evaluation

Patients Blinded By Tainted Eye Pharmaceuticals

On behalf of Kaiser Gornick LLP posted in Dangerous Pharmaceuticals on Friday, December 14, 2012 Bevacizumab injections prepared by a Florida compounding pharmacy blinded almost a dozen patients according to news reports. The patients were given bevacizumab, also known as [...]

By Kaiser Gornick LLP|2019-05-24T08:06:07+00:00December 14th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

State Pharmacy Board Director Fired After Meningitis Outbreak

Massachusetts Board of Pharmacy director James Coffey was recently fired after a failing to provide enough pharmacy oversight before the deadly fungal meningitis outbreak that has sickened hundreds and killed around 30. Officials say that Coffey failed to disclose a [...]

By Kaiser Gornick LLP|2019-05-24T08:05:23+00:00December 12th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

BMJ Editorial Calls For Publication Of Pharmaceutical Clinical Trial Data

A recent editorial in the British Medical Journal calls on pharmaceutical companies to make all of their clinical trial data available to public scrutiny. Although drugmakers have saved countless lives with their innovations and breakthroughs, many companies continue to hide [...]

By Kaiser Gornick LLP|2019-05-24T08:04:44+00:00December 7th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

USA Today Study: Compounding Pharmacies Rarely Held Accountable

A study recently published by USA Today reveals that compounding pharmacies are rarely held accountable for producing dangerous pharmaceuticals such as the NECC back injections that caused a nationwide fungal meningitis outbreak. Reporters looked at legal action taken by regulatory [...]

By Kaiser Gornick LLP|2019-05-24T08:03:58+00:00December 5th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

ASBESTOS-RELATED ILLNESSES RAMPANT IN SOME MINING TOWNS

Asbestos is a naturally-occurring mineral that was mined for over a century for use in thousands of products. The use of asbestos products was severely restricted in the late 1970s because it became well-known that asbestos causes a variety of [...]

By Kaiser Gornick LLP|2019-05-24T11:24:06+00:00November 15th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

INVESTIGATION REVEALS THAT FDA CLEARED UNTESTED PHARMACEUTICALS FOR SALE

A recent article from Forbes Magazine highlights the extreme gaps in the U.S. Food and Drug Administration's approval process for potentially dangerous pharmaceutical drugs. The FDA is notorious for failing to thoroughly scrutinize the claims that pharmaceutical companies make regarding [...]

By Kaiser Gornick LLP|2019-05-24T11:23:23+00:00November 12th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

HOSPIRA RECALLS IV SOLUTIONS DUE TO MOLD CONTAMINATION

Drugmaker Hospira Inc. has recalled some of its IV solution products due to a report of mold contamination which may endanger patients. The U.S. Food and Drug Administration announced that the recall impacts Lactated Ringer's and 5% Dextrose Injection, USP, [...]

By Kaiser Gornick LLP|2019-05-24T11:22:26+00:00November 8th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

FDA Issues Recall Notice about TorFlex Transseptal Guiding Sheath Kit

The FDA recently warned of a recall affecting TorFlex Transseptal Guiding Sheath Kit manufactured between December 2011 and July 2013. The maker of this defective medical device, Baylis Medical Company Inc., recalled the device and issued an Urgent Device Recall [...]

By Kaiser Gornick LLP|2019-05-24T11:21:35+00:00November 7th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

CONTAMINATED BACK STEROID BLAMED FOR AT LEAST 28 PATIENT DEATHS

The investigation into a deadly meningitis outbreak continues after a defective pharmaceutical killed over two dozen patients and sickened over 386. Authorities say that a fungus-contaminated steroid was shipped clinics in at least 23 states from a specialty pharmacy in [...]

By Kaiser Gornick LLP|2019-05-24T11:20:50+00:00November 5th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

FDA warns numerous dietary supplements might cause serious cardiovascular health issues

The FDA recently warned that its lab analysis has identified an undeclared ingredient in multiple dietary supplements marketed as natural remedies for weight loss. The ingredient in question - sibutramine - "was removed from the U.S. market in October 2010 [...]

By Kaiser Gornick LLP|2019-05-24T11:28:15+00:00October 16th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

AVANDIA AND ACTOS LINKED TO BLINDNESS IN DIABETES PATIENTS

A recent article in the New York Times indicates that popular diabetes drugs such as Avandia and Actos have been linked to blindness in some patients. The article highlights the dangers of thiazolidinediones, a group of diabetes medications that have [...]

By Kaiser Gornick LLP|2019-05-24T11:27:11+00:00September 13th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

REPORT: J&J CONTINUED SELLING DEFECTIVE VAGINAL MESH AFTER FDA WARNING

We have covered many vaginal mesh implant cases in previous posts. Although medical device manufacturer Johnson & Johnson agreed to stop selling these defective medical devices this summer, more evidence indicates that the company was aware that these products should [...]

By Kaiser Gornick LLP|2019-05-24T11:26:27+00:00September 10th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

CALIFORNIA WOMAN AWARDED $5 MILLION IN VAGINAL MESH CASE

In our last post, we discussed the wave of litigation brought against medical device company Johnson & Johnson over its defective transvaginal mesh implants. Hundreds of lawsuits have been filed against J&J and other mesh implant manufacturers by women who [...]

By Kaiser Gornick LLP|2019-05-24T11:25:49+00:00September 6th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

SURGICAL CLIP MANUFACTURER MAY FACE FAILURE-TO-WARN LITIGATION

California product liability claims typically fall under one of three legal theories: design defects, manufacturing defects and failure-to-warn of known hazards. CNN reports that manufacturers of surgical clips may face failure-to-warn product liability litigation from kidney donors who suffered serious [...]

By Kaiser Gornick LLP|2019-05-24T11:25:11+00:00September 3rd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

GSK PAYS $3 BILLION SETTLEMENT FOR ILLEGAL PHARMACEUTICAL MARKETING

In our last post, we discussed a $3 billion settlement agreed to by drugmaker GlaxoSmithKline to settle allegations that it illegally marketed dangerous pharmaceuticals for unapproved, off-label uses. In addition to the antidepressant Paxil, authorities allege that the drugmaker mismarketed [...]

By Kaiser Gornick LLP|2019-05-24T11:29:39+00:00August 30th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

GLAXOSMITHKLINE ADMITS TO IMPROPERLY MARKETING PAXIL

British pharmaceutical giant GlaxoSmithKline (GSK) recently agreed to pay a record-breaking $3 billion settlement for the improper marketing of many dangerous pharmaceuticals, including Paxil. Federal regulators say that the drugmaker marketed several of its drugs for unapproved, off-label uses. This [...]

By Kaiser Gornick LLP|2019-05-24T11:28:58+00:00August 28th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

LAWSUIT DETAILS THE DANGERS OF PFIZER’S SMOKING CESSATION DRUG CHANTIX

In our last post, we discussed a recent pharmaceutical liability lawsuit filed against drugmaker Pfizer Inc. and its California distributor. Several users of Pfizer's smoking cessation drug Chantix allege that Pfizer failed to warn them that the drug could cause [...]

By Kaiser Gornick LLP|2019-05-24T11:32:49+00:00July 12th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

PFIZER SUED IN LOS ANGELES FOR CHANTIX SIDE EFFECTS

Pfizer Inc. and its California distributor, McKesson Corp., were recently sued in Los Angeles Superior Court by dozens of individuals who suffered adverse side effects after taking the drug varenicline, also known as Chantix. Chantix is designed to mimic the [...]

By Kaiser Gornick LLP|2019-05-24T11:31:56+00:00July 10th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

RESEARCHERS CONCERNED BY INADEQUATE FDA RECALL NOTIFICATION SYSTEMS

Researchers say that the Food and Drug Administration's system of recall notifications is inadequate and may expose patients to defective pharmaceuticals long after a recall is issued. ABC News reported on a study covering FDA notifications for the most serious [...]

By Kaiser Gornick LLP|2019-05-24T11:31:15+00:00July 6th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

BAYER AG TO PAY $100M AFTER BIRTH CONTROL PILLS LINKED TO BLOOD CLOTS

German drugmaker Bayer AG is set to pay more than $100 million to settle hundreds of lawsuits brought by women alleging that its Yasmin birth control pills cause dangerous blood clots. Several Yasmin-related blood clots have caused fatal strokes and [...]

By Kaiser Gornick LLP|2019-05-24T11:30:27+00:00July 3rd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

J&J ANNOUNCES THAT IT WILL STOP SALES OF DANGEROUS TRANSVAGINAL MESH IMPLANTS

Medical device giant Johnson & Johnson recently told a federal judge that it plans to stop sales of four of itstransvaginal mesh implants. The announcement by J&J's Ethicon unit comes at a time when the company faces hundreds of lawsuits [...]

By Kaiser Gornick LLP|2019-05-24T11:37:14+00:00June 30th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

FDA GIVES GREEN LIGHT TO POTENTIALLY DANGEROUS WEIGHT LOSS DRUG

The Food and Drug Administration recently approved the first prescription diet drug in a decade. The drug, Belviq, is made by Arena Pharmaceuticals, which claims that it can help obese dieters lose weight by modifying their brain chemistry to create [...]

By Kaiser Gornick LLP|2019-05-24T11:36:37+00:00June 29th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

DEFECTIVE DEFIBRILLATOR KILLS PATIENT

Boston Scientific recently revealed that a medical device defect in its implantable cardiac defibrillators has killed at least one person. The defect is present in the company's Cognis and Teligen defibrillators which have already been implanted in over 233,000 patients [...]

By Kaiser Gornick LLP|2019-05-24T11:35:40+00:00June 11th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

TRANSVAGINAL MESH LAWSUITS MOVE NORTH OF THE BORDER

The wave of transvaginal mesh lawsuits have spilled across the border to Canada. Medical device giant Johnson & Johnson faces a newly minted class action in Canada in addition to the massive wave of transvaginal mesh cases in California and [...]

By Kaiser Gornick LLP|2019-05-24T11:35:04+00:00June 8th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

INTUITIVE FACES WRONGFUL DEATH LAWSUIT OVER DA VINCI ROBOT

The father of a 24-year-old patient recently filed a product liability lawsuit against Intuitive Surgical, Inc. alleging that the company's da Vinci surgical robot led to his daughter's death. The patient died two weeks after her hysterectomy surgery and her [...]

By Kaiser Gornick LLP|2019-05-24T11:34:26+00:00June 6th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

“THE CONSUMER EXPECTATIONS TEST” IN MESOTHELIOMA LITIGATION

This week, we have discussed a mesothelioma case involving a California oil refinery worker's family. The worker died after developing mesothelioma and his family filed a product liability lawsuit against the manufacturer of the asbestos-containing insulation that likely caused the [...]

By Kaiser Gornick LLP|2019-05-24T11:33:40+00:00June 2nd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

DEFECTIVE DESIGN THEORY IN CALIFORNIA PRODUCT LIABILITY LAW

In our last post, we discussed a wrongful death and product liability lawsuit brought by the family of a California oil refinery worker who died of mesothelioma. The family brought the lawsuit against the manufacturer of asbestos insulation that the [...]

By Kaiser Gornick LLP|2019-05-24T11:40:10+00:00May 31st, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

REFINERY WORKER’S FAMILY BRINGS MESOTHELIOMA LAWSUIT AGAINST MANUFACTURER

The family of a former California oil refinery worker recently brought a wrongful death and product liability lawsuit against the manufacturer of asbestos insulation. Many individuals throughout California have been exposed to asbestos-containing materials in the workplace. Asbestos is a [...]

By Kaiser Gornick LLP|2019-05-24T11:39:29+00:00May 29th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

ABBOTT LABORATORIES TO PAY $1.5 BILLION FOR MISMARKETING DEPAKOTE

It is not uncommon for large drugmakers to market drugs for uses that have not been approved by the U.S. Food and Drug Administration. This practice, known as "off-label marketing," can result in billions of dollars in profits for drugmakers, [...]

By Kaiser Gornick LLP|2019-05-24T11:38:46+00:00May 24th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

TAKEDA FAILS TO GET FDA APPROVAL FOR ACTOS FOLLOW-UP

The giant drugmaker Takeda Pharmaceutical Co. has failed to secure federal approval to market its follow-up to the diabetes drug Actos. Takeda sought to sell its diabetes drug, called alogliptin, in the U.S., but the Food and Drug Administration has [...]

By Kaiser Gornick LLP|2019-05-24T11:38:04+00:00May 22nd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

RISPERDAL SETTLEMENT CLIMBS TO $1.8 BILLION

Pharmaceutical giant Johnson & Johnson may have to pay upwards of $1.8 billion to settle a serious lawsuit with the Justice Department and several states arising out of the marketing of the antipsychotic Risperdal. Authorities say the company marketed Risperdal [...]

By Kaiser Gornick LLP|2019-05-24T11:45:19+00:00April 27th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

ACTOS LAWSUIT ACCUSES TAKEDA OF COVERING UP ADVERSE DRUG EFFECTS

A recently unsealed whistleblower complaint alleges that the U.S. arm of Japanese drugmaker Takeda Pharmaceutical Co. hid the adverse effects of its blockbuster diabetes drug Actos. The lawsuit alleges that Takeda Pharmaceuticals North America Inc. intentionally hid the fact that [...]

By Kaiser Gornick LLP|2019-05-24T11:44:43+00:00April 25th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

REPORT: DANGEROUS SURGICAL MESH WAS NOT TESTED

A recent investigation by Consumer Reports indicates that transvaginal mesh was not tested before it was released to the market. Transvaginal mesh is just one of many defective medical devices that the Food and Drug Administration (FDA) allowed onto the [...]

By Kaiser Gornick LLP|2019-05-24T11:43:59+00:00April 23rd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

ACTOS MAKER REACHES $800M DEAL TO BUY URL PHARMA

Drugmaker Takeda Pharmaceutical Co. Ltd. recently reached a deal to buy Philadelphia-based URL Pharma Inc., a maker of gout treatment medication, for $800 million. The deal is expected to close within the next two months. Takeda is the Japanese drugmaker [...]

By Kaiser Gornick LLP|2019-05-24T11:43:11+00:00April 20th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

NEW STUDY REVEALS HEALTH RISKS POSED BY ENTIRE CLASS OF METAL-ON-METAL HIP IMPLANTS

A new investigative study by the British Medical Journal (BMJ) shows a potential for significant danger with all or most metal-on-metal hip implants. In addition to higher than average failure rates, the metal-on-metal implants can leach metal ions into the [...]

By Kaiser Gornick LLP|2019-05-24T11:42:31+00:00March 2nd, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

VAGINAL MESH CAUSING PROBLEMS FOR MANY WOMEN

Every year, thousands of women experience pelvic organ prolapse - a condition in which organs in the abdomen prolapse (bulge) into the vaginal area. Generally, doctors treat this condition by surgically implanting mesh between the abdomen and the vaginal area [...]

By Kaiser Gornick LLP|2019-05-24T11:41:52+00:00February 6th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

HIP INJURY RATES MAY SPELL MORE LAWSUITS IN THE U.S.

For those with arthritis and other diseases of the joints, replacement surgeries can improve quality of life and mobility. In 2007, almost 800,000 knee and hip replacements were performed. It is estimated that more than 750,000 Americans have replacement surgery [...]

By Kaiser Gornick LLP|2019-05-24T11:41:13+00:00January 16th, 2012|Blog Posts in 2012, News Blog|0 Comments
Read More

Recent Posts

  • Identifying Nursing Home Abuse: Warning Signs
  • Problems With the Zimmer Persona Knee System
  • What Are the Dangers of Zofran?
  • Signs of Mesothelioma
  • FDA Recalls Liquid Pharmaceutical Products

Categories

  • Blog Posts in 2010
  • Blog Posts in 2012
  • Blog Posts in 2013
  • Blog Posts in 2014
  • Blog Posts in 2015
  • Blog Posts in 2016
  • Blog Posts in 2017
  • Blog Posts in 2018
  • Legal Articles
  • News Blog
  • Mass Tort Trial Lawyers Association
  • Super Lawyers
  • The National Trial Lawyers
  • Million Dollar Advocates Forum
  • American Association for Justice
  • San Francisco Trial Lawyers Association
  • Consumer Attorneys of California
  • The Bar Association of San Francisco
Call Today!
Kaiser Gornick LLP – California Defective Products Lawyers
3195 Danville Blvd., Suite 2
Alamo, CA 94507 View Map

Ph: 415-857-7400


Designed by Mindweb Technologies
  • Practice Areas
  • Testimonials
  • Site Map
  • Privacy Policy
  • Contact Us
  • Get a Free Case Evaluation
The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.